BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34724084)

  • 41. Thyroid-stimulating hormone levels after radiotherapy and combined therapy for head and neck cancer.
    Weissler MC; Berry BW
    Head Neck; 1991; 13(5):420-3. PubMed ID: 1938359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thyroid dysfunction following therapeutic external radiation to head and neck cancer.
    Chougule A; Kochar B
    Asian Pac J Cancer Prev; 2011; 12(2):443-5. PubMed ID: 21545210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypothyroidism after head-and-neck radiotherapy in children and adolescents: preliminary results of the "Registry for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence" (RiSK).
    Bölling T; Geisenheiser A; Pape H; Martini C; Rübe C; Timmermann B; Fischedick K; Kortmann RD; Gerss J; Koch R; Willich N
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e787-91. PubMed ID: 21167655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nutritional counseling with or without systematic use of oral nutritional supplements in head and neck cancer patients undergoing radiotherapy.
    Cereda E; Cappello S; Colombo S; Klersy C; Imarisio I; Turri A; Caraccia M; Borioli V; Monaco T; Benazzo M; Pedrazzoli P; Corbella F; Caccialanza R
    Radiother Oncol; 2018 Jan; 126(1):81-88. PubMed ID: 29111172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral Nutritional Supplementation Affects the Dietary Intake and Body Weight of Head and Neck Cancer Patients during (Chemo) Radiotherapy.
    Ferreira IB; Lima EDNS; Canto PPL; Gontijo CA; Maia YCP; Pena GDG
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32825254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Iatrogenc hypothyroidism: a consequence of external beam radiotherapy to the head & neck malignancies.
    Aich RK; Ranjan DA; Pal S; Naha BL; Amitabh R
    J Cancer Res Ther; 2005; 1(3):142-6. PubMed ID: 17998645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dose-volume derived nomogram as a reliable predictor of radiotherapy-induced hypothyroidism in head and neck cancer patients.
    Prpic M; Kruljac I; Kust D; Suton P; Purgar N; Bilos LK; Gregov M; Mrcela I; Franceschi M; Djakovic N; Frobe A
    Radiol Oncol; 2019 Nov; 53(4):488-496. PubMed ID: 31747379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of nutritional interventions on nutritional status, quality of life and mortality in patients with head and neck cancer receiving (chemo)radiotherapy: a systematic review.
    Langius JA; Zandbergen MC; Eerenstein SE; van Tulder MW; Leemans CR; Kramer MH; Weijs PJ
    Clin Nutr; 2013 Oct; 32(5):671-8. PubMed ID: 23845384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The threshold of hypothyroidism after radiation therapy for head and neck cancer: a retrospective analysis of 116 cases.
    Fujiwara M; Kamikonya N; Odawara S; Suzuki H; Niwa Y; Takada Y; Doi H; Terada T; Uwa N; Sagawa K; Hirota S
    J Radiat Res; 2015 May; 56(3):577-82. PubMed ID: 25818629
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of Nutrition Counseling in Head and Neck Cancer Sufferers Undergoing Antineoplastic Therapy: A Randomized Controlled Pilot Study.
    Dai W; Wang SA; Wang K; Chen C; Wang J; Chen X; Yan J
    Curr Oncol; 2022 Sep; 29(10):6947-6955. PubMed ID: 36290823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy.
    Chyan A; Chen J; Shugard E; Lambert L; Quivey JM; Yom SS
    Radiat Oncol; 2014 Dec; 9():269. PubMed ID: 25476839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Individualized Prophylactic Neck Irradiation in Patients with cN0 Head and Neck Cancer Based on Sentinel Lymph Node(s) Identification: Definitive Results of a Prospective Phase 1-2 Study.
    Longton E; Lawson G; Bihin B; Mathieu I; Hanin FX; Deheneffe S; Vander Borght T; Laloux M; Daisne JF
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(4):652-661. PubMed ID: 32294522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thyroid dysfunction following radiotherapy for head and neck cancer.
    Turner SL; Tiver KW; Boyages SC
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):279-83. PubMed ID: 7836081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.
    Diaz R; Jaboin JJ; Morales-Paliza M; Koehler E; Phillips JG; Stinson S; Gilbert J; Chung CH; Murphy BA; Yarbrough WG; Murphy PB; Shyr Y; Cmelak AJ
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):468-76. PubMed ID: 19577867
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: Clinical validation according to the model-based approach.
    Christianen ME; van der Schaaf A; van der Laan HP; Verdonck-de Leeuw IM; Doornaert P; Chouvalova O; Steenbakkers RJ; Leemans CR; Oosting SF; van der Laan BF; Roodenburg JL; Slotman BJ; Bijl HP; Langendijk JA
    Radiother Oncol; 2016 Feb; 118(2):298-303. PubMed ID: 26700602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and validation of a machine learning model of radiation-induced hypothyroidism with clinical and dose-volume features.
    Tsai MH; Chang JTC; Lu HH; Wu YH; Pao TH; Cheng YJ; Zheng WY; Chou CY; Lin JH; Yu T; Chiang JH
    Radiother Oncol; 2023 Dec; 189():109911. PubMed ID: 37709053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hypothyroidism after radiotherapy of the neck area: monitoring of thyroid function is important].
    Smit M; Kerstens MN; Boomsma-van Holten MJ; van der Meer K; Zijlstra JG; Links TP
    Ned Tijdschr Geneeskd; 2014; 158():A6714. PubMed ID: 24548592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: the role of dosimetric and clinical factors.
    Beetz I; Schilstra C; Burlage FR; Koken PW; Doornaert P; Bijl HP; Chouvalova O; Leemans CR; de Bock GH; Christianen ME; van der Laan BF; Vissink A; Steenbakkers RJ; Langendijk JA
    Radiother Oncol; 2012 Oct; 105(1):86-93. PubMed ID: 21632133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Postradiation hypothyroidism in head and neck cancers: A Department of Veterans Affairs single-institution case-control dosimetry study.
    Lin AJ; Zhang J; Cho-Lim J; Inouye W; Lee SP
    Med Dosim; 2019 Spring; 44(1):56-60. PubMed ID: 29580932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nutritional changes in patients with locally advanced head and neck cancer during treatment.
    Arribas L; Hurtós L; Taberna M; Peiró I; Vilajosana E; Lozano A; Vazquez S; Mesia R; Virgili N
    Oral Oncol; 2017 Aug; 71():67-74. PubMed ID: 28688694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.